Neurology

Comprehensive Summary

Darekar et al. studied the aging of the brain using artificial intelligence (AI), especially in people with mild cognitive impairment (MCI) and Alzheimer's disease (AD). The researchers used various AI models to predict brain age using MRI scans from 825 people to identify patterns related to normal aging and aging linked with MCI and AD. They used a deep learning model called AgeNet, integrated with tools such as SHapley Additive exPlanation, local interpretable model-agnostic explanations, and layer-wise relevance propagation to identify regions that were significant in predicting the age of the brain. Researchers found that AgeNet was the best AI model at predicting the brain age and identifying regions of the brain that are impacted by MCI and AD, surpassing traditional models. From the experimental data, MCI patients showed mild differences in brain regions compared to the cognitively normal participants. AD patients, on the other hand, displayed broader and more severe changes in comparison to individuals with normal cognition, highlighting the critical aging of the brain. These AI-driven tools prove to be promising technologies that can be used to make early detection of aging from the structural brain changes. They help in tracking neurodegenerative disease progression, with a potential to make personalized treatment plans for patients suffering from such diseases.

Outcomes and Implications

This research is important in uncovering the aging process of the brain and understanding how the aging affects diseases like MCI and AD. By showing the regional distribution of changes in the brain using AgeNet, the research could provide a huge breakthrough with a personalized treatment approach based on every individuals’ brain condition. In regards to medicine, this technology would be useful in early diagnosis of neurodegenerative diseases like MCI and AD for necessary action to be taken before its symptoms worsen. It also would help in monitoring the progression of these diseases over time, giving physicians the ability to customize treatment plans for their patients. This technology is still being researched, but can be extended to trials with larger populations, allowing for detailed age-related insights using stronger data outputs.

Our mission is to

Connect medicine with AI innovation.

No spam. Only the latest AI breakthroughs, simplified and relevant to your field.

Our mission is to

Connect medicine with AI innovation.

No spam. Only the latest AI breakthroughs, simplified and relevant to your field.

Our mission is to

Connect medicine with AI innovation.

No spam. Only the latest AI breakthroughs, simplified and relevant to your field.

AIIM Research

Articles

© 2025 AIIM. Created by AIIM IT Team

AIIM Research

Articles

© 2025 AIIM. Created by AIIM IT Team

AIIM Research

Articles

© 2025 AIIM. Created by AIIM IT Team